Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes.

Journal of lipid research - 1 Jun 2009

Connelly Philip W, Zinman Bernard, Maguire Graham F, Mamakeesick Mary, Harris Stewart B, Hegele Robert A, Retnakaran Ravi, Hanley Anthony J G

Abstract excerpt

Paraoxonase 1 (PON1) has been reported to be associated with proteinuria in subjects with type 2 diabetes mellitus (T2DM). Plasma cystatin C is more accurate than creatinine for identifying stage 3 kidney disease in T2DM. We tested the hypothesis that PON1 and cystatin C would be associated in T2DM subjects from an Aboriginal Canadian community, who are at high risk for the development of nephropathy. PON1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryldialkylphosphatase
Share to Canada

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Cystatin C

Share to Diabetes Complications

Share to Glomerular Filtration Rate

Share to Indians, North American

Share to Regression Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 19151417
DOI: 10.1194/jlr.P800070-JLR200
PMCID: PMC2681404

Genes

PON1
PON2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes.PMID 19151417Read ↗

Paraoxonase 1 (PON1) L55M and Q192R polymorphisms are not associated with chronic kidney disease in Thai individuals with type 2 diabetes.Semantic proximity Read ↗

Genetic polymorphisms of paraoxonase-1 are associated with chronic kidney disease in Japanese women.Semantic proximity Read ↗

Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76.Semantic proximity Read ↗

Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation.Semantic proximity Read ↗

Genetic association analyses highlight apolipoprotein B as a determinant of chronic kidney disease in patients with type 2 diabetes.Semantic proximity Read ↗

Evaluation of polymorphisms in paraoxonase 2 (PON2) gene and their association with cardiovascular-renal disease risk in Mexican Americans.Semantic proximity Read ↗

Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.Semantic proximity Read ↗

Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.Semantic proximity Read ↗

Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.Semantic proximity Read ↗

Association between PON 1 polymorphisms, PON activity and diabetes complications.Semantic proximity Read ↗

Enzyme Activity and Genetic Polymorphisms of Paraoxonase 1 in Patients With Type 2 Diabetes Mellitus: A Case-Control StudySemantic proximity Read ↗

Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.